Currently submitted to: JMIR Rehabilitation and Assistive Technologies
Date Submitted: Dec 23, 2025
Open Peer Review Period: Jan 20, 2026 - Mar 17, 2026
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Generative Artificial Intelligence in Cerebral Palsy Rehabilitation: A Systematic Scoping Review, Ethical Challenges, and Future Perspectives
ABSTRACT
Background:
Cerebral Palsy (CP) is the most frequent motor disability in childhood, with a higher prevalence in low- and middle-income countries where access to essential early rehabilitation is limited. Generative Artificial Intelligence (GenAI) emerges as a disruptive technology with potential to address these challenges. This scoping reviews maps the current landscape of GenAI applications in CP rehabilitation.
Objective:
To systematically review and synthesize literature on the use of GenAI in CP rehabilitation, analyzing its applications, reported benefits, technical/ethical challenges, and future research directions.
Methods:
A systematic search was conducted following PRISMA 2020 guidelines across five databases (PubMed/MEDLINE, Scopus, Web of Science, IEEE Xplore, Google Scholar) through October 2025. Studies utilizing generative models (LLMs, GANs, VAEs, diffusion models) for diagnosis, assessment, therapy planning, documentation, or education in CP were included. Screening and data extraction were performed independently by two reviewers.
Results:
From 487 initial records, 32 studies (2022-2025) were included, indicating a nascent field dominated by research in high-income countries. Large Language Models (LLMs) constituted 75% of applications. Four key application categories were identified: 1. Diagnosis/Assessment: LLMs enabled early CP detection from clinical notes (Sensitivity:82%); GANs synthesized movement data to improve GMFCS classification accuracy from 72% to 90%. 2. Therapy Planning: LLMs generated personalized exercise regimens (quality 7.8/10 vs. expert 8.9/10); AI-designed VR content increased therapy adherence by >40%. 3. Clinical Documentation: Automation reduced note-writing time by 55%; AI decision support showed 80% concordance with clinical guidelines. 4. Patient/Caregiver Education: Tailored educational materials significantly improved family knowledge scores. Reported benefits included enhanced personalization, efficiency, and accessibility. Critical challenges included hallucinations/factual errors, data privacy concerns, algorithmic bias, a lack of interpretability, and risks of dehumanization.
Conclusions:
GenAI presents significant potential to augment CP rehabilitation by scaling personalization and improving efficiency. However, current evidence is primarily proof-of-concept. Responsible implementation necessitates: (1) robust clinical trials focusing on functional outcomes, (2) development of domain-specific models, (3) ethical frameworks addressing bias and accountability, (4) strategies for equitable global access, and (5) professional training for AI-augmented practice. GenAI should amplify, not replace, the therapist's expertise and the human therapeutic connection. Our collective choices will determine its ultimate impact on care.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.